• Immuno-Oncology-slider

    Leaders in IO services; PBMC, DC, T cell, Macrophage/TAMs, T cell tumour killing and more

  • Immunology-Slider-Zoomed2

    Specialized Screening Platforms; Innate and Adaptive Immune Cell Function, Phenotypic Screening and Beyond

Immuno-Oncology icon

Immuno-Oncology

IMMUNO-ONCOLOGY

MORE INFO

Immunology Services icon

Immunology Services

IMMUNOLOGY

MORE INFO

Regeneration Services button

Regeneration Services

REGENERATION

MORE INFO

Histology Services icon

Histology Services

HISTOLOGY

MORE INFO

About Aquila section

ABOUT AQUILA BIOMEDICAL

Aquila BioMedicalAquila BioMedical is an innovative preclinical contract research organization that offers clients world leading research expertise in Immuno-Oncology, Immunology and Regeneration.

Bespoke services combine advanced models with protocolled techniques, to provide high-value data, defining both efficacy and the mechanism of action of drug candidate compounds. A key feature of the Aquila offering is the partnering of services with world-leading academics to provide expert advice and interpretation of the data.

Click here to learn more about us >

Focus Box

WHAT’S HAPPENING AT AQUILA

Aquila is currently developing Human Tumour Ex-vivo Systems with materials that could be used for compound screening.

Developing high throughput and 3D nanofiber OPC cultures for compound screening.

The team at Aquila are excited to announce the launch of our Journal Club! Please see latest news for more information.